Jan 18, 2013 by Dave Williamson and Max MacalusoAlnylam Investors: Hit With DilutionUnpleasant dilution for Alnylam investors.
Jan 18, 2013 by Dave Williamson and Max MacalusoDendreon's Critical Clinical TrialsSuccess is vital for Dendreon in its 2013 clinical trials.
Jan 18, 2013 by Dave Williamson and Max MacalusoAVEO Investors: Hit With DilutionUnpleasant dilution for AVEO investors.
Jan 18, 2013 by Dave Williamson and Max MacalusoOnyx Investors: Hit With DilutionUnpleasant dilution for Onyx investors.
Jan 18, 2013 by Dave Williamson and Max MacalusoAegerion Investors: Hit With DilutionUnpleasant dilution for Aegerion investors.
Jan 18, 2013 by Dave Williamson and Max MacalusoTrius Investors: Hit With DilutionUnpleasant share dilution for Trius investors.
Jan 17, 2013 by Dave WilliamsonDendreon's Secret Silver LiningA piece of good news in a sea of uncertainty.
Jan 17, 2013 by Dave WilliamsonWall Street Hates These 2 BiotechsBrean Capital unleashes two aggressive downgrades.
Jan 14, 2013 by Dave Williamson and Max MacalusoIs Wall Street Right About Intuitive Surgical?Is there an emerging bear case for Intuitive Surgical?
Jan 14, 2013 by Dave Williamson and Max MacalusoDendreon's Big New PushSome aggressive new marketing from Dendreon.
Jan 14, 2013 by Dave Williamson and Max MacalusoIs Halozyme Back?Can this pharma company make a comeback?
Jan 13, 2013 by Dave Williamson and austin smithDendreon: The Risks TodayWhat investors need to know.
Jan 13, 2013 by Dave Williamson and austin smithDendreon: 3 Key Factors to KnowSome essentials for investors to follow.
Jan 13, 2013 by Dave Williamson and austin smithDendreon: Foolish Management ReviewGreat investors always take a close look at a company's management before investing. What do we think of Dendreon's?
Jan 11, 2013 by Dave WilliamsonIs Teva Just Looking Out for Itself It sent the FDA a citizens' petition regarding a pending competitor.
Jan 11, 2013 by Dave WilliamsonIs Dendreon Recapturing Wall Street's Imagination?Sanford Bernstein thinks its a double
Jan 11, 2013 by Dave Williamson and Max MacalusoIsis Wins at Wooing Wall StreetThere's a lot ahead for 2013.
